Shentong Technology Group (605228.SH): Beheng Investment plans to reduce its shareholding by no more than 3%

19:55 13/03/2026

Shentong Technology (605228.SH) announced that its shareholder Bi Heng Investment plans to reduce its total holding of the company's shares by no more than 14.37 million shares through centralized bidding and block trading due to its own capital needs, with a reduction ratio not exceeding 3% of the company's total share capital.

Shentong Technology Group (605228.SH) announced that its shareholder, Bi Heng Investment, plans to reduce its total holdings of the company's shares by no more than 14.37 million shares through centralized bidding and block trading, representing no more than 3% of the company's total share capital, due to its own financial needs.

CF PHARMTECH's self-developed inhaled powder aerosol candidate drug ICF001's IND application has been accepted by the NMPA.

Goldman Sachs' latest research report: The World Cup is not only a feast for football fans, but also a "highlight moment" for these US stock sectors.

YOFC (06869) plans to invest HK$31.3 million to subscribe for private equity fund shares, aiming to expand in the cutting-edge technology sector.

CF PHARMTECH's self-developed inhaled powder aerosol candidate drug ICF001's IND application has been accepted by the NMPA.

Goldman Sachs' latest research report: The World Cup is not only a feast for football fans, but also a "highlight moment" for these US stock sectors.

YOFC (06869) plans to invest HK$31.3 million to subscribe for private equity fund shares, aiming to expand in the cutting-edge technology sector.